ICH Guideline Suggests ‘Weight of Evidence’ Analysis Before Nonclinical Pediatric Trials

Drug Industry Daily
A A
Sponsors should consider whether they need to conduct nonclinical safety experiments on drugs before moving on to pediatric trials, according to an ICH draft guideline the FDA released for comment on Tuesday.

To View This Article:

Login

Subscribe To Drug Industry Daily